SMTI Stock Overview
Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Sanara MedTech Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$34.01 |
| 52 Week High | US$48.66 |
| 52 Week Low | US$26.06 |
| Beta | 1.63 |
| 1 Month Change | -8.67% |
| 3 Month Change | -7.81% |
| 1 Year Change | -26.99% |
| 3 Year Change | 24.72% |
| 5 Year Change | 608.54% |
| Change since IPO | -96.37% |
Recent News & Updates
Recent updates
Is Sanara MedTech (NASDAQ:SMTI) Using Too Much Debt?
Nov 15
Investors Still Waiting For A Pull Back In Sanara MedTech Inc. (NASDAQ:SMTI)
May 22Sanara MedTech Inc. (NASDAQ:SMTI) Analysts Are Pretty Bullish On The Stock After Recent Results
Mar 22Sanara MedTech: Differentiated Offering With Niche Wound Care Exposure
Sep 06Sanara MedTech reports Q2 results
Aug 15Here's Why We're Not At All Concerned With Sanara MedTech's (NASDAQ:SMTI) Cash Burn Situation
Dec 31Sanara MedTech: Technology For Faster Healing Wounds
Dec 08Sanara Medtech inks exclusive partnership with Pixalere Healthcare
Jun 04Companies Like Sanara MedTech (NASDAQ:SMTI) Can Afford To Invest In Growth
May 18Neil Cataldi From Blueprint Discusses Sanara MedTech
May 03The Sanara MedTech (NASDAQ:SMTI) Share Price Has Soared 510%, Delighting Many Shareholders
Feb 19
Is Sanara MedTech Inc. (NASDAQ:SMTI) Popular Amongst Insiders?
Dec 28Shareholder Returns
| SMTI | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 3.2% | -4.1% | -3.7% |
| 1Y | -27.0% | -2.2% | 20.5% |
Return vs Industry: SMTI underperformed the US Medical Equipment industry which returned -2.2% over the past year.
Return vs Market: SMTI underperformed the US Market which returned 20.5% over the past year.
Price Volatility
| SMTI volatility | |
|---|---|
| SMTI Average Weekly Movement | 6.4% |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SMTI has not had significant price volatility in the past 3 months.
Volatility Over Time: SMTI's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 108 | Zach Fleming | sanaramedtech.com |
Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. It also provides BIAKOS Antimicrobial Skin and Wound Cleanser, a patented product that contains synergistic ingredients that have been shown to impact mature biofilm microbes; BIAKOS Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing that helps against planktonic microbes, as well as immature and mature biofilms; and BIAKOS Antimicrobial Skin and Wound Irrigation Solution.
Sanara MedTech Inc. Fundamentals Summary
| SMTI fundamental statistics | |
|---|---|
| Market cap | US$272.48m |
| Earnings (TTM) | -US$4.30m |
| Revenue (TTM) | US$64.99m |
4.5x
P/S Ratio-68.1x
P/E RatioIs SMTI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SMTI income statement (TTM) | |
|---|---|
| Revenue | US$64.99m |
| Cost of Revenue | US$7.85m |
| Gross Profit | US$57.14m |
| Other Expenses | US$61.44m |
| Earnings | -US$4.30m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.50 |
| Gross Margin | 87.92% |
| Net Profit Margin | -6.62% |
| Debt/Equity Ratio | 21.7% |
How did SMTI perform over the long term?
See historical performance and comparison